Page 141 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 141
Imiquimod: physicians’ awareness, attitudes and experiences
References
1. van Seters M, van Beurden M, ten Kate FJ, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. T N Engl J Med. 2008;358:1465-1473.
2. Management of vulvar intraepithelial neoplasia. Committee Opinion No. 509. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;118:1192–1194.
3. Royal College of Obstetricians and Gynaecologists. Green–top Guideline No. 58: The Management of Vulval Skin Disorders. London: RCOG; 2011. [cited 2015 Aug 10] Available at: https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_58.pdf.
4. Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17(5 Suppl 1):S1-S27.
5. Crane JM. Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstet Gynecol. 2003;102:1058-1062.
6. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al. Obstetric outcomes after conservative
treatment for intraepithelial or early invasive cervical lesions: systematic review and meta- 7 analysis. Lancet. 2006;367:489-498
7. Gurumurthy M, Cruickshank ME. Management of vaginal intraepithelial neoplasia. J Low Genit Tract Dis. 2012;16:306-312.
8. Gunderson CC, Nugent EK, Elfrink SH, Gold MA, Moore KN. A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol. 2013;208:410.e1-6.
9. Buck HW, Guth KJ. Treatment of vaginal intraepithelial neoplasia (primarily low grade) with imiquimod 5% cream. J Low Genit Tract Dis. 2003;3:290-293.
10. Haidopoulos D, Diakomanolis E, Rodolakis A, et al. Can local application of imiquimod cream be an alternative mode of therapy for patients with high-grade intraepithelial lesions of the vagina? Int J Gynecol Cancer. 2005;15:898-902.
11. Grimm C, Polterauer S, Natter C, et al. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial. Obstet Gynecol. 2012;120:152-159.
12. Pachman DR, Barton DL, Clayton AC, et al. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia. Am J Obstet Gynecol. 2012;206:42 e1-7.
13. Lin CT, Qiu JT, Wang CJ, et al. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia. Taiwan J Obstet Gynecol. 2012;51:533-538.
14. Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6:e34.
15. Group T, Sharp L, Cotton S, et al. After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial. BJOG. 2009;116:1506-14.
16. Dunn TS, Killoran K, Wolf D. Complications of outpatient LLETZ procedures. J Reprod Med. 2004;49:76-8.
17. England LJ, Anderson BL, Tong VT, et al. Screening practices and attitudes of obstetricians- gynecologists toward new and emerging tobacco products. Am J Obstet Gynecol. 2014;211:695. e1-7.
139
